Tau aggregates: Toxic, inert, or protective species?

Journal of Alzheimer's Disease

Volumn 14, Issue 4, 2008, Pages 431-436

  Bretteville, Alexis ^a   Planel, Emmanuel ^a,b  

^a NewYork Presbyterian Hospital   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Neurofibrillary tangles; Tau; Toxicity

Indexed keywords

AMYLOID BETA PROTEIN; OLIGOMER; TAU PROTEIN; TRANSCRIPTION FACTOR;

ALZHEIMER DISEASE; AMNESIA; COGNITIVE DEFECT; HYPERPHOSPHORYLATION; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NEUROTOXICITY; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; REVIEW; SYNAPTIC POTENTIAL; TOXICITY;

EID: 49149098525     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-14411     Document Type: Review

References (55)

1. A.C. Alonso, I. Grundke-Iqbal and K. Iqbal, Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules, Nat Med 2 (1996), 783-787.
2. A.C. Alonso, T. Zaidi, M. Novak, I. Grundke-Iqbal and K. Iqbal, Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments / straight filaments, Proc Natl Acad Sci USA 98 (2001), 6923-6928.
3. A.C. Alonso, B. Li, I. Grundke-Iqbal and K. Iqbal, Polymerization of hyperphosphorylated tau into filaments eliminates its inhibitory activity, Proc Natl Acad Sci U S A 103 (2006), 8864-8869.
4. T. Arendt, J. Stieler, A.M. Strijkstra, R.A. Hut, J. Rudiger, E.A. Van der Zee, T. Harkany, M. Holzer and W. Hartig, Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals, J Neurosci 23 (2003), 6972-6981.
5. J. Avila, J.J. Lucas, M. Perez and F. Hernandez, Role of tau protein in both physiological and pathological conditions, Physiol Rev 84 (2004), 361-384.
6. C. Bancher, C. Brunner, H. Lassmann, H. Budka, K. Jellinger, G. Wiche, F. Seitelberger, I. Grundke-Iqbal, K. Iqbal and H.M. Wisniewski, Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease, Brain Res 477 (1989), 90-99.
7. C. Bancher, I. Grundke-Iqbal, K. Iqbal, V.A. Fried, H.T. Smith and H.M. Wisniewski, Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease, Brain Res 539 (1991), 11-18.
8. Z. Berger, H. Roder, A. Hanna, A. Carlson, V. Rangachari, M. Yue, Z. Wszolek, K. Ashe, J. Knight, D. Dickson, C. Andorfer, T.L. Rosenberry, J. Lewis, M. Hutton and C. Janus, Accumulation of pathological tau species and memory loss in a conditional model of tauopathy, J Neurosci 27 (2007), 3650-3662.
9. L.I. Binder, A.L. Guillozet-Bongaarts, F. Garcia-Sierra and R.W. Berry, Tau, tangles, and Alzheimer's disease, Biochim Biophys Acta 1739 (2005), 216-223.
10. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol, 82 (1991), 239-259.
11. H. Braak and E. Braak, Frequency of stages of Alzheimer-related lesions in different age categories, Neurobiol. Aging 18 (1997), 351-357.
12. R. Brandt, M. Hundelt and N. Shahani, Tau alteration and neuronal degeneration in tauopathies: mechanisms and models, Biochim Biophys Acta 1739 (2005), 331-354.
13. J.P. Brion, C. Smith, A.M. Couck, J.M. Gallo and B.H. Anderton, Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer's disease, J Neurochem 61 (1993), 2071-2080.
14. L. Buee, T. Bussiere, V. Buee-Scherrer, A. Delacourte and P.R. Hof, Tau protein isoforms, phosphorylation and role in neurodegenerative disorders, Brain Res Brain Res Rev 33 (2000), 95-130.
15. L.M. Callahan and P.D. Coleman, Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease, Neurobiol Aging 16 (1995), 311-314.
16. K.A. Chalmers and S. Love, Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons, J Neuropathol Exp Neurol 66 (2007), 158-167.
17. A. Delacourte, J.P. David, N. Sergeant, L. Buee, A. Wattez, P. Vermersch, F. Ghozali, C. Fallet-Bianco, F. Pasquier, F. Lebert, H. Petit and C. Di Menza, The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease, Neurology 52 (1999), 1158-1165.
18. P. Delaere, C. Duyckaerts, J.P. Brion, V. Poulain and J.J. Hauw, Tau, paired helical filaments and amyloid in the neocortex: a morphometric study of 15 cases with graded intellectual status in aging and senile dementia of Alzheimer type, Acta Neuropathol (Berl) 77 (1989), 645-653.
19. K. Duff, H. Knight, L.M. Refolo, S. Sanders, X. Yu, M. Picciano, B. Malester, M. Hutton, J. Adamson, M. Goedert, K. Burki and P. Davies, Characterization of Pathology in Transgenic Mice Over-Expressing Human Genomic and cDNA Tau Transgenes, Neurobiol Dis 7 (2000), 87-98.
20. K. Duff and E. Planel, Untangling memory deficits, Nat Med 11 (2005), 826-827.
21. C. Duyckaerts, M. Bennecib, Y. Grignon, T. Uchihara, Y. He, F. Piette and J.J. Hauw, Modeling the relation between neurofibrillary tangles and intellectual status, Neurobiol Aging 18 (1997), 267-273.
22. C. Duyckaerts and J.J. Hauw, Prevalence, incidence and duration of Braak's stages in the general population: can we know, Neurobiol Aging 18 (1997), 362-369; discussion 389-392.
23. C. Duyckaerts, M.A. Colle, F. Dessi, F. Piette and J.J. Hauw, Progression of Alzheimer histopathological changes, Acta Neurol Belg 98 (1998), 180-185.
24. T. Engel, P. Goni-Oliver, J.J. Lucas, J. Avila and F. Hernandez, Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert, J Neurochem 99 (2006), 1445-1455.
25. T. Engel, J.J. Lucas, F. Hernandez and J. Avila, Amouse model to study tau pathology related with tau phosphorylation and assembly, J Neurol Sci 257 (2007), 250-254.
26. T.C. Gamblin, F. Chen, A. Zambrano, A. Abraha, S. Lagalwar, A.L. Guillozet, M. Lu, Y. Fu, F. Garcia-Sierra, N. LaPointe, R. Miller, R.W. Berry, L.I. Binder and V.L. Cryns, Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease, Proc Natl Acad Sci U S A 100 (2003), 10032-10037.
27. P. Giannakopoulos, F.R. Herrmann, T. Bussiere, C. Bouras, E. Kovari, D.P. Perl, J.H. Morrison, G. Gold and P.R. Hof, Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease, Neurology 60 (2003), 1495-1500.
28. G.G. Glenner and C.W. Wong, Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein, Biochem Biophys Res Commun 120 (1984), 885-890.
29. M. Goedert, R. Jakes, R.A. Crowther, J. Six, U. Lubke, M. Vandermeeren, P. Cras, J.Q. Trojanowski and V.M. Lee, The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development, Proc Natl Acad Sci U S A 90 (1993), 5066-5070.
30. T. Gomez-Isla, R. Hollister, H. West, S. Mui, J.H. Growdon, R.C. Petersen, J.E. Parisi and B.T. Hyman, Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease, Ann Neurol 41 (1997), 17-24.
31. I. Grundke-Iqbal, K. Iqbal, Y.C. Tung, M. Quinlan, H.M. Wisniewski and L.I. Binder, Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology, Proc. Natl. Acad. Sci. U.S.A. 83 (1986), 4913-4917.
32. A.L. Guillozet-Bongaarts, F. Garcia-Sierra, M.R. Reynolds, P.M. Horowitz, Y. Fu, T. Wang, M.E. Cahill, E.H. Bigio, R.W. Berry and L.I. Binder, Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease, Neurobiol Aging 26 (2005), 1015-1022.
33. J. Hardy and D.J. Selkoe, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science 297 (2002), 353-356.
34. M. Hutton, C.L. Lendon, P. Rizzu, M. Baker, S. Froelich, H. Houlden, S. Pickering-Brown, S. Chakraverty, A. Isaacs, A. Grover, J. Hackett, J. Adamson, S. Lincoln, D. Dickson, P. Davies, R.C. Petersen, M. Stevens, E. de Graaff, E. Wauters, J. van Baren, M. Hillebrand, M. Joosse, J.M. Kwon, P. Nowotny, L.K. Che, J. Norton, J.C. Morris, L.A. Reed, J. Trojanowski, H. Basun, L. Lannfelt, M. Neystat, S. Fahn, F. Dark, T. Tannenberg, P.R. Dodd, N. Hayward, J.B. Kwok, P.R. Schofield, A. Andreadis, J. Snowden, D. Craufurd, D. Neary, F. Owen, B.A. Oostra, J. Hardy, A. Goate, J. van Swieten, D. Mann, T. Lynch and P. Heutink, Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17, Nature 393 (1998), 702-705.
35. T. Kimura, S. Yamashita, T. Fukuda, J.M. Park, M. Murayama, T. Mizoroki, Y. Yoshiike, N. Sahara and A. Takashima, Hyperphosphorylated tau in parahippocampal cortex impairs place learning in aged mice expressing wild-type human tau, Embo J 26 (2007), 5143-5152.
36. S. Le Corre, H.W. Klafki, N. Plesnila, G. Hubinger, A. Obermeier, H. Sahagun, B. Monse, P. Seneci, J. Lewis, J. Eriksen, C. Zehr, M. Yue, E. McGowan, D.W. Dickson, M. Hutton and H.M. Roder, An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice, Proc Natl Acad Sci U S A 103 (2006), 9673-9678.
37. S. Maeda, N. Sahara, Y. Saito, S. Murayama, A. Ikai and A. Takashima, Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease, Neurosci Res 54 (2006), 197-201.
38. S. Maeda, N. Sahara, Y. Saito, M. Murayama, Y. Yoshiike, H. Kim, T. Miyasaka, S. Murayama, A. Ikai and A. Takashima, Granular tau oligomers as intermediates of tau filaments, Biochemistry 46 (2007), 3856-3861.
39. M.M. Mocanu, A. Nissen, K. Eckermann, I. Khlistunova, J. Biernat, D. Drexler, O. Petrova, K. Schonig, H. Bujard, E. Mandelkow, L. Zhou, G. Rune and E.M. Mandelkow, The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy, J Neurosci 28 (2008), 737-748.
40. R. Morsch, W. Simon and P.D. Coleman, Neurons may live for decades with neurofibrillary tangles, J Neuropathol Exp Neurol 58 (1999), 188-197.
41. W. Noble, E. Planel, C. Zehr, V. Olm, J. Meyerson, F. Suleman, K. Gaynor, L. Wang, J. LaFrancois, B. Feinstein, M. Burns, P. Krishnamurthy, Y. Wen, R. Bhat, J. Lewis, D. Dickson and K. Duff, Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo, Proc Natl Acad Sci U S A 102 (2005), 6990-6995.
42. E. Planel, Y. Tatebayashi, T. Miyasaka, L. Liu, L. Wang, M. Herman, W.H. Yu, J.A. Luchsinger, B. Wadzinski, K.E. Duff and A. Takashima, Insulin dysfunction induces in vivo tau hyperphosphorylation through distinct mechanisms, J Neurosci 27 (2007), 13635-13648.
43. D. Pollak, N. Cairns and G. Lubec, Cytoskeleton derangement in brain of patients with Down syndrome, Alzheimer's disease and Pick's disease, J Neural Transm Suppl (2003), 149-158.
44. M. Rapoport, H.N. Dawson, L.I. Binder, M.P. Vitek and A. Ferreira, Tau is essential to beta -amyloid-induced neurotoxicity, Proc Natl Acad Sci U S A (2002).
45. R.A. Rissman, W.W. Poon, M. Blurton-Jones, S. Oddo, R. Torp, M.P. Vitek, F.M. LaFerla, T.T. Rohn and C.W. Cotman, Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology, J Clin Invest 114 (2004), 121-130.
46. E.D. Roberson, K. Scearce-Levie, J.J. Palop, F. Yan, I.H. Cheng, T. Wu, H. Gerstein, G.Q. Yu and L. Mucke, Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model, Science 316 (2007), 750-754.
47. N. Sahara, S. Maeda, M. Murayama, T. Suzuki, N. Dohmae, S.H. Yen and A. Takashima, Assembly of two distinct dimers and higher-order oligomers from full-length tau, Eur J Neurosci 25 (2007), 3020-3029.
48. K. Santacruz, J. Lewis, T. Spires, J. Paulson, L. Kotilinek, M. Ingelsson, A. Guimaraes, M. DeTure, M. Ramsden, E. McGowan, C. Forster, M. Yue, J. Orne, C. Janus, A. Mariash, M. Kuskowski, B. Hyman, M. Hutton and K.H. Ashe, Tau suppression in a neurodegenerative mouse model improves memory function, Science 309 (2005), 476-481.
49. S. Sato, Y. Tatebayashi, T. Akagi, D.H. Chui, M. Murayama, T. Miyasaka, E. Planel, K. Tanemura, X. Sun, T. Hashikawa, K. Yoshioka, K. Ishiguro and A. Takashima, Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells, J Biol Chem 277 (2002), 42060-42065.
50. A.M. Shiarli, R. Jennings, J. Shi, K. Bailey, Y. Davidson, J. Tian, E.H. Bigio, B. Ghetti, J.R. Murrell, M.B. Delisle, S. Mirra, B. Crain, P. Zolo, K. Arima, E. Iseki, S. Murayama, H. Kretzschmar, M. Neumann, C. Lippa, G. Halliday, J. Mackenzie, N. Khan, R. Ravid, D. Dickson, Z. Wszolek, T. Iwatsubo, S.M. Pickering-Brown and D.M. Mann, Comparison of extent of tau pathology in patients with frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17), frontotemporal lobar degeneration with Pick bodies and early onset Alzheimer's disease, Neuropathol Appl Neurobiol 32 (2006), 374-387.
51. P.Q. Sumpter, D.M. Mann, C.A. Davies, P.O. Yates, J.S. Snowden and D. Neary, An ultrastructural analysis of the effects of accumulation of neurofibrillary tangle in pyramidal neurons of the cerebral cortex in Alzheimer's disease, Neuropathol Appl Neurobiol 12 (1986), 305-319.
52. R.D. Terry, The pathogenesis of Alzheimer disease: an alternative to the amyloid hypothesis, J Neuropathol Exp Neurol 55 (1996), 1023-1025.
53. J.Q. Trojanowski and V.M. Lee, Paired helical filament tau in Alzheimer's disease. The kinase connection, Am J Pathol 144 (1994), 449-453.
54. Y. Yoshiyama, M. Higuchi, B. Zhang, S.M. Huang, N. Iwata, T.C. Saido, J. Maeda, T. Suhara, J.Q. Trojanowski and V.M. Lee, Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model, Neuron 53 (2007), 337-351.
55. A. Yuan, A. Kumar, C. Peterhoff, K. Duff and R.A. Nixon, Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice, J Neurosci 28 (2008), 1682-1687.